The Role of Data and Safety Monitoring in Acute Trauma Resuscitation Research

Journal of the American College of Surgeons

Volumn 204, Issue 1, 2007, Pages 73-83

  Champion, Howard R ^a   Fingerhut, Abe ^b   Escobar, Miguel A ^c   Weiskopf, Richard B ^d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^c UNIVERSITY OF TEXAS   (United States)

^d NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACCURACY; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD CLOTTING DISORDER; BLUNT TRAUMA; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EMERGENCY HEALTH SERVICE; EVALUATION; FEMALE; FUNDING; HUMAN; INFORMATION PROCESSING; INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT MONITORING; PENETRATING TRAUMA; PRIORITY JOURNAL; RESUSCITATION; SAFETY; STANDARDIZATION; THROMBOEMBOLISM;

ACUTE DISEASE; DATA COLLECTION; DOUBLE-BLIND METHOD; FACTOR VII; HEMORRHAGE; HUMANS; MONITORING, PHYSIOLOGIC; RECOMBINANT PROTEINS; RESUSCITATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; WOUNDS, NONPENETRATING; WOUNDS, PENETRATING;

EID: 33845640413     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.10.024     Document Type: Article

References (37)

1. NIH Policy for Data and Safety Monitoring. Release date: June 10, 1998. Available at: http://grants2.nih.gov/grants/guide/notice-files/not98-084.html. Accessed May 1, 2006.
2. US Food and Drug Administration. Guidance for clinical trial sponsors, establishment and operation of clinical trial data monitoring committees. FDA March 2006. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/01d-0489-gdl0003.pdf. Accessed May 15, 2006.
3. European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Human Use. Guideline on data monitoring committees. July 2005. Available at: http://www.emea.eu.int/pdfs/human/ewp/587203en.pdf. Accessed May 15, 2006.
4. World Health Organization. Operational guidelines for the establishment and functioning of data and safety monitoring boards (2005). http://www.who.int/tdr/publications/publications/operat_guidelines.htm http://www.who.int/tdr/publications/publications/operat_guidelines.htm. Accessed May 15, 2006.
5. Slutsky A.S., and Lavery J.V. Data safety and monitoring boards. N Engl J Med 350 (2004) 1143-1147
6. Steinbrook R. Public registration of clinical trials. N Engl J Med 351 (2004) 315-317
7. Morse M.A., Califf R.M., and Sugarman J. Monitoring and ensuring safety during clinical research. JAMA 285 (2001) 1201-1205
8. Scheifele D.S., Duval B., De Serres G., and Skowronski D.M. Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications. Control Clin Trials 24 (2003) 99-104
9. Collins J.F. Data and safety monitoring board issues raised in the VA Status Epilepticus Study. Control Clin Trials 24 (2003) 71-77
10. Champion HR, Weiskopf RB, Fingerhut A, et al. Patient safety evaluation in a major clinical trial evaluating a new drug. Presented at the annual meeting of the American Association for the Surgery of Trauma, September 29-October 1, 2004, Maui, HI.
11. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-18
12. World Health Organization. New publications show injuries kill more than five million people a year. Available at: http://www.who.int/mediacentre/news/releases/2003/pr40/en/. Accessed February 16, 2005.
13. National Center for Health Statistics, Centers for Disease Control and Prevention. Fast stats A to Z. All injuries. Updated on January 19, 2005. Available at: http://www.cdc.gov/nchs/fastats/injury.htm. Accessed February 16, 2005.
14. Champion H.R., Bellamy R.F., Roberts P., and Leppaniemi A. A profile of combat injury. J Trauma 54 Suppl 5S (2003) S13-S19
15. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 38 (1995) 185-193
16. Sloan E.P., Koenigsberg M., Gens D., et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. A randomized controlled efficacy trial. JAMA 282 (1999) 1857-1864
17. Committee on Fluid Resuscitation for Combat Casualties, Institute of Medicine. Fluid resuscitation: State of the science for treating combat casualties and civilian injuries (1999), National Academies Press, Washington, DC. http://www.nap.edu/catalog/9625.html Available at: http://www.nap.edu/catalog/9625.html. Accessed August 1, 2006
18. Roberts H.R., Monroe D.M., and Escobar M.A. Current concepts of hemostasis: implications for therapy. Anesthesiology 1000 (2004) 722-730
19. Holcomb J.B. Methods for improved hemorrhage control. Crit Care 8 Suppl 2 (2004) S57-S60
20. Levy J.H., Fingerhut A., Brott T., et al. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46 (2006) 919-933
21. Levi M., Peters M., and Buller H.R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33 (2005) 883-890
22. DAMOCLES Study Group. A proposed charter for clinical trial 2005 data monitoring committees: helping them do their job well. Lancet 365 (2005) 711-722
23. Issues in data monitoring and interim analysis of trials (DAMOCLES). University of Aberdeen, Health Services Research Unit. Last modified December 2, 2005. Available at: http://www.abdn.ac.uk/hsru/hta/damocles.shtml. Accessed May 16, 2006.
24. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Clinical research. Data and safety monitoring board (DSMB) guidelines. Available at: http://www.niaid.nih.gov/dmid/clinresearch/dsm.htm. Accessed February 17, 2005.
25. Bolland K., and Whitehead J. Formal approaches to safety monitoring of clinical trials in life-threatening conditions. Stat Med 19 (2000) 2899-2917
26. Edwards I.R., and Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356 (2000) 1255-1259
27. McCullock P., Taylor I., Susako M., et al. Randomised trials in surgery. Problems and possible solutions. Br Med J 324 (2002) 1448-1451
28. King M., Nazareth I., Lampe F., et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review. JAMA 293 (2005) 1089-1099
29. Fergusson D., Aaron S.D., Guyatt G., and Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. Br Med J 325 (2002) 652-654
30. Stiell I.G., Hebert P.C., Wells G.A., et al. Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial. Lancet 358 (2001) 105-109
31. Department of Health and Human Services. Institutional review boards. A time for reform. Washington, DC: Department of Health and Human Services, DHHS Office of the Inspector General, June 1998. (DHHS contract no. OEI-01-97-N00193).
32. Burman W.J., Reves R.R., Cohn D.L., and Schooley R.T. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med 134 (2001) 152-157
33. Relman A.S., and ACCME. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. JAMA 289 (2003) 2418-2420
34. Ioannidis J.P., and Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285 (2001) 437-443
35. Steinbrook R. Gag clauses in clinical-trial agreements. N Engl J Med 352 (2005) 2160-2162
36. DeAngelis C.D., Drazen J.M., Frizelle F.A., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 292 (2004) 1363-1364
37. World Health Organization. WHO leads drive for international coordination of clinical research (2005). http://www.who.int/mediacentre/news/releases/2004/pr23/en/ Available at: http://www.who.int/mediacentre/news/releases/2004/pr23/en/. Accessed February 23, 2005